Drug intelligence / Profile preview

(S)-mandelic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

(S)-Mandelic acid is the dextrorotatory enantiomer of mandelic acid, a chiral aromatic alpha-hydroxy acid with the molecular formula C8H8O3 and a molecular weight of 152.15 g/mol. It appears as a white to light yellow crystalline powder, soluble in water and polar organic solvents. This compound is widely used as an intermediate in the synthesis of pharmaceuticals—particularly antibiotics and anti-infective agents—and serves as a resolving agent for racemic mixtures in analytical chemistry. In cosmetics, it is valued for its exfoliating properties and antimicrobial activity, making it suitable for skin care formulations targeting dull or acne-prone skin. As an alpha-hydroxy acid, it promotes cell turnover and has demonstrated antibacterial effects against both Gram-positive and Gram-negative bacteria. Industrial production methods include chemical synthesis from mandelonitrile or biotechnological fermentation using engineered E. coli or Saccharomyces cerevisiae strains expressing hydroxymandelate synthase[1][5][8][10].

Other names
(S)-2-hydroxy-2-phenylacetic acidL-mandelatemandelic aci(S)-hydroxyphenylaceticacidL-(+)-mandelsureL-amygdalic acidS-(+)-mandeLS-(+)-mandelic

Beyond the preview

Go deeper on (S)-mandelic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (S)-mandelic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call